What Is Retatrutide and Is It Approved Yet?

Unable to add items

Sorry, we're unable to add the item because your cart is already full.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Failed to remove from Wish List.

Please try again later

Adding to library failed

Please try again

Unable to follow podcast

Unable to unfollow podcast

What Is Retatrutide and Is It Approved Yet?

Listen for free

View show details

Season's Savings | 0.99 €/month for 3 months

5.99 €/month thereafter - terms apply. Cancel monthly.

Retatrutide is an investigational “triple agonist” drug that targets GLP‑1, GIP, and glucagon receptors to reduce appetite and affect metabolism. It’s shown promising, sometimes double‑digit percentage weight loss in early trials, but it has not received FDA approval and needs larger, longer studies to confirm safety and long‑term effectiveness — so it isn’t available as a routine prescription today. For more information visit https://southfloridatrimclinic.com/.

No reviews yet